Artemis Medicare Services Ltd. 22nd AGM: All resolutions passed, dividend declared.
Artemis Medicare Services Limited's 22nd AGM on July 31, 2026, passed all resolutions. Key approvals include audited financial statements for FY26, a final dividend of ₹0.45 per share, re-appointment of statutory auditors, and appointment of two independent directors. Remuneration for cost auditors and non-executive directors was also approved.
The passing of resolutions related to financial statements, dividend, director appointments, and auditor re-appointment are standard corporate events but indicate smooth functioning and management approval, which has a medium impact on investor confidence and company operations.
The announcement reports the successful passing of all resolutions at the AGM, including the declaration of a dividend and the appointment of directors and auditors, indicating positive corporate governance and shareholder engagement.
Artemis Medicare Services Limited held its 22nd Annual General Meeting (AGM) on Friday, July 31, 2026, where all eight items on the agenda were passed by the members. The meeting, conducted through Video Conferencing, saw the approval of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026. A final dividend of ₹0.45 per equity share for the financial year ended March 31, 2026, was declared. The appointment of Ms. Shalini Kanwar Chand as a Director was re-affirmed, and M/s. T R Chadha & Co LLP were re-appointed as Statutory Auditors. The remuneration for Cost Auditors for the financial year 2026-27 was ratified. Additionally, Mr. Tapan Mitra and Dr. Girdhar Jessaram Gyani were appointed as Independent Directors through special resolutions. The payment of remuneration by way of commission to Non-Executive Directors was also approved as an ordinary resolution. The detailed voting results and the report of the Scrutinizer dated July 31, 2026, were submitted.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.